|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS: | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-earning deposits in financial institutions | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Securities held-to-maturity, at amortized cost (fair value of $250,285 and $262,460 at September 30, 2023 and December 31, 2022) | ||||||||||||||||||||
| Securities available-for-sale, at fair value (amortized cost of $968,009 and $909,563 at September 30, 2023 and December 31, 2022; allowance for credit losses of $1,036 and $0 at September 30, 2023 and December 31, 2022) | ||||||||||||||||||||
| Total cash, cash equivalents, and restricted cash | ||||||||||||||||||||
| Securities AFS, at fair value, net of allowance for credit losses (amortized cost of $0 and $2,646,414, respectively)(ACL of $— and $775, respectively) | ||||||||||||||||||||
| Securities held-to-maturity, at amortized cost, net of allowance for credit losses (fair value of $2,227,000 and $2,246,526, respectively)(ACL of $695 and $695, respectively) | ||||||||||||||||||||
| Securities HTM, at amortized cost, net of allowance for credit losses (fair value of $0 and $2,246,526, respectively)(ACL of $0 and $695, respectively) | ||||||||||||||||||||
| FRB and FHLB stock, at cost | ||||||||||||||||||||
| Total investment securities | ||||||||||||||||||||
| Loans HFS | ||||||||||||||||||||
| Loans held for investment, net | ||||||||||||||||||||
| Loans and leases held for investment | ||||||||||||||||||||
| Deferred fees, net | ||||||||||||||||||||
| Total loans and leases held for investment, net | ||||||||||||||||||||
| Federal Home Loan Bank and other bank stock, at cost | ||||||||||||||||||||
| Loans and leases HFI | ||||||||||||||||||||
| Allowance for loan and lease losses | ||||||||||||||||||||
| Total loans and leases HFI, net | ||||||||||||||||||||
| Equipment leased to others under operating leases | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Investments in alternative energy partnerships, net | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Income tax receivable | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangibles | ||||||||||||||||||||
| Derivative assets | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Noninterest-bearing deposits | ||||||||||||||||||||
| Interest-bearing deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Federal Home Loan Bank (FHLB) advances, net and Federal Reserve Bank (FRB) borrowings | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Borrowings (including $110,363 and $113,634 at fair value, respectively) | ||||||||||||||||||||
| Subordinated debt | ||||||||||||||||||||
| Accrued interest payable and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY: | ||||||||||||||||||||
| Preferred stock | ||||||||||||||||||||
| Common Stock, Shares, Outstanding | ||||||||||||||||||||
| Common Stock | ||||||||||||||||||||
| Class B Common Stock | ||||||||||||||||||||
| Common Stock | ||||||||||||||||||||
| Class B non-voting | ||||||||||||||||||||
| Total common Stock, Shares, Outstanding | ||||||||||||||||||||
| Common stock ($0.01 par value, shares issued and outstanding at June 30, 2026; 150,039,018 shares issued and 149,963,520 outstanding at December 31, 2025) | ||||||||||||||||||||
| Common Stock | ||||||||||||||||||||
| Class B Common Stock | ||||||||||||||||||||
| Common Stock | ||||||||||||||||||||
| Class B Non-Voting | ||||||||||||||||||||
| Class B non-voting | ||||||||||||||||||||
| Total common stock ($0.01 par value, shares issued and outstanding at June 30, 2026; 150,039,018 shares issued and 149,963,520 outstanding at December 31, 2025) | ||||||||||||||||||||
| Non-voting common stock equivalents ($0.01 par value, 9,790,600 shares issued at March 31, 2025 and 9,790,600 shares issued at December 31, 2024) | ||||||||||||||||||||
| Class B Non-voting common stock ($0.01 par value, 477,321 shares issued at March 31, 2025 and 477,321 share issued at December 31, 2024) | ||||||||||||||||||||
| Non-voting common stock equivalents ($0.01 par value, — shares issued at June 30, 2026 and 5,017,064 shares issued at December 31, 2025) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained deficit | ||||||||||||||||||||
| Treasury stock, at cost (8,383,337 and 6,623,846 shares at September 30, 2023 and December 31, 2022) | ||||||||||||||||||||
| Accumulated other comprehensive loss, net | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
| Other Borrowings, Fair Value Disclosure | ||||||||||||||||||||
Loading...
